发明名称 Human protein tyrosine phosphatase inhibitors and methods of use
摘要 The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis.
申请公布号 US9126958(B2) 申请公布日期 2015.09.08
申请号 US201414569106 申请日期 2014.12.12
申请人 AERPIO THERAPEUTICS, INC. 发明人 Gray Jeffrey Lyle;Amarasinghe Kande K. D.;Clark Cynthia Monesa;Nichols Ryan Matthew;Maier Matthew B.
分类号 A61K31/4965;A61K31/497;A61K31/44;A61K31/425;C07D277/28;C07D417/04;C07D277/60 主分类号 A61K31/4965
代理机构 Wilson Sonsini Goodrich & Rosati 代理人 Wilson Sonsini Goodrich & Rosati
主权项 1. A compound of the formula: R is a thiazolyl group that is substituted or unsubstituted; R1 is alkyl, phenyl, or benzyl, any of which is substituted or unsubstituted, or hydrogen; R2 is alkyl or alkoxy; and R3 is hydrogen or alkyl,or a pharmaceutically-acceptable salt thereof.
地址 Cincinnati OH US